Welsh G I, Patel J C, Proud C G
Department of Biosciences, University of Kent at Canterbury, United Kingdom.
Anal Biochem. 1997 Jan 1;244(1):16-21. doi: 10.1006/abio.1996.9838.
In this study we describe the characterization and use of new peptide substrates for assaying glycogen synthase kinase-3 (GSK-3) which are based on the sequence around the single GSK-3 phosphorylation site in the translation factor eIF2B. The new peptides offer important advantages over previous substrates, which were based on the sequence around the multiple GSK-3 phosphorylation sites in glycogen synthase (GS), for the assay of GSK-3 in cell extracts. In particular, decreases in GSK-3 activity following, e.g., insulin treatment, are partially or completely masked when the GS-based peptides are used but are readily measured using the new, eIF2B-based, peptides. The new peptides, unlike those based on GS, are therefore suitable for the assay of changes in GSK-3 activity in cell extracts without the need for prior immunoprecipitation or ion-exchange chromatography.
在本研究中,我们描述了基于翻译因子eIF2B中单个糖原合酶激酶-3(GSK-3)磷酸化位点周围序列的新型肽底物的特性及用途,用于检测GSK-3。与先前基于糖原合酶(GS)中多个GSK-3磷酸化位点周围序列的底物相比,这些新型肽在检测细胞提取物中的GSK-3时具有重要优势。特别是,当使用基于GS的肽时,例如胰岛素处理后GSK-3活性的降低会被部分或完全掩盖,但使用基于eIF2B的新型肽则很容易检测到。因此,与基于GS的肽不同,新型肽无需预先进行免疫沉淀或离子交换色谱,即可用于检测细胞提取物中GSK-3活性的变化。